TTK Healthcare Ltd.’s standalone net profit from continuing operations for the June quarter rose fourfold to ₹16 crore from the year-earlier period.
Net profit after tax was ₹16 crore against ₹601 crore. The results for the previous year included profit from the discontinued operations (sale of human pharma division) of ₹597 crore after deducting tax expenses.
Revenue from operations jumped to ₹202 crore from ₹193 crore, the healthcare company said in a regulatory filing.
This is a Premium article available exclusively to our subscribers. To read 250+ such premium articles every
month
You have exhausted your free article limit.
Please support quality journalism.
You have exhausted your free article limit.
Please support quality journalism.
The Hindu operates by its editorial values to provide you quality journalism.
You have read {{data.cm.views}} out of {{data.cm.maxViews}} free articles.
This is your last free article.